SGTX - Sigilon Therapeutics EPS beats by $0.03 misses on revenue November, 10 2021 05:06 PM Sigilon Therapeutics Inc. Sigilon Therapeutics (NASDAQ:SGTX): Q3 GAAP EPS of -$0.63 beats by $0.03. Revenue of $1.95M (-53.6% Y/Y) misses by $0.95M. Press Release For further details see: Sigilon Therapeutics EPS beats by $0.03, misses on revenue